BridgeBio Pharma (BBIO) Property, Plant & Equipment (Net) Growth (3y) (2021 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | BridgeBio Pharma | 12.91 Bn | 11.98 Bn | 184.58 Mn | -28.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -28.59% |
| Dec 31, 2025 | -28.32% |
| Sep 30, 2025 | -27.97% |
| Jun 30, 2025 | -28.73% |
| Mar 31, 2025 | -26.95% |
| Dec 31, 2024 | -38.45% |
| Sep 30, 2024 | -32.06% |
| Jun 30, 2024 | -27.92% |
| Mar 31, 2024 | -20.62% |
| Dec 31, 2023 | -16.54% |
| Sep 30, 2023 | -8.46% |
| Jun 30, 2023 | -5.73% |
| Mar 31, 2023 | -4.86% |
| Dec 31, 2022 | 37.33% |
| Sep 30, 2022 | 73.57% |
| Jun 30, 2022 | 210.07% |
| Dec 31, 2021 | 167.26% |